Examination of the quality and complications of diagnosis in percutaneous kidney biopsy affected by difference of biopsy needle

Examination of the quality and complications of diagnosis in percutaneous kidney biopsy affected by difference of biopsy needle - Are there differences in quality and complications due to differences in biopsy needles?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037490

Enrollment

100

Registered

2019-07-31

Start date

2019-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD

Interventions

We randomly assign renal biopsy patients to be performed at our hospital to those using a 16G puncture needle and those using an 18G puncture needle. All other methods are performed with the same prot

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic kidney disease who undergo a kidney biopsy at our hospital are included in this study. Patients should be informed after sufficient explanation.

Exclusion criteria

Exclusion criteria: Patients who do not give consent. Those who have a tendency to bleed. Specifically, those who are abnormal in the platelet count and PT and APTT tests are excluded.

Design outcomes

Primary

Measure	Time frame
Is there a difference in safety regardless of the difference in the biopsy needle? In particular, is the amount of bleeding different between two groups? Is there a difference in the number of collected glomeruli?	—

Countries

Japan

Contacts

Public Contactseiji Hashimoto

Kinan Hospital Department Of Nephrology

seijinih@med.hokudai.ac.jp0739-22-5000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026